Skip to content

Insider · CIK 0001824633

Krishna Vaddi

ceoofficerdirector

Files at PRLD (Prelude Therapeutics Inc). First filing Dec 20, 2024, latest Dec 20, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$99k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PRLD: Prelude Therapeutics Inc

PRLDOct 9, 2026 · close 3.89

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
53Moderate
PRLDbuy 3
Prelude Therapeutics Inc
$99k
106,888 shares
+10%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 18, 2024PRLD
Prelude Therapeutics Inc
POpen-market purchase
Common Stock
+100,000$0.93$93k1,167,275Dec 20, 2024
Dec 19, 2024PRLD
Prelude Therapeutics Inc
POpen-market purchase
Common Stockindirect: See footnote
+6,888$0.89$6,116127,553Dec 20, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Krishna Vaddi: insider trades and track record | InsiderTell